risks of microdosing glp 1 GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment People Are Microdosing Weight-Loss Drugs
Description
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are an important advancement in treating obesity and type 2 diabetes as they increase insulin secretion after meals without triggering hypoglycemia, helping reduce appetite and consequently body weight
[PubMed ID: 25789296]
Insulin, incretins and other growth factors as potential novel treatments for Alzheimers and Parkinsons diseases
BMJ 344:d7771 Correale M, Monaco I, Brunetti ND, Di Biase M, Metra M, Nodari S, Butler J, Gheorghiade M (2018) Master Program Students on Drug Development for Heart Failure
